Share Page:

Volume 19 , Issue 2
March/April 2004

Pages 288Ė290

Implant Surgery for a Patient with Parkinsonís Disease Controlled by Intravenous Midazolam: A Case Report

Keiji Kubo, DDS, PhD/Kayo Kimura, DDS, PhD

PMID: 15101602

A 72-year-old male patient with Parkinsonís disease referred to the Dental Hospital of Kyushu University, Fukuoka, Japan, presented with movement of an implant-supported prosthesis, slight pain, and purulent drainage from the gingiva in the anterior region of the maxilla, where implants had been placed more than 20 years earlier. He requested that the mobile implant and prosthesis be removed and was in need of implant therapy in his maxilla. In addition to Parkinsonís disease the patient had a severe gag reflex, which made treatment difficult. A total of 6 treatments were required. New implants were successfully placed while the patient was under anesthesia (a combination of intravenously administered 3% prilocaine hydrochloride and vasopressin); midazolam was also administered intravenously. The results of this case indicate that use of regional anesthesia in combination with midazolam can be recommended for implant surgery in patients with Parkinsonís disease. Intravenous midazolam can be considered the sedative of choice for the surgical treatment of patients suffering from systemic disease. INT J ORAL MAXILLOFAC IMPLANTS 2004;19:288Ė290

Full Text PDF File | Order Article


Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.


© 2017 Quintessence Publishing Co, Inc JOMI Home
Current Issue
Ahead of Print
Author Guidelines
Accepted Manuscripts
Submission Form
Quintessence Home
Terms of Use
Privacy Policy
About Us
Contact Us